Seattle biotech Alpine Immune Sciences raises $91M for drug development
September 15, 2021 at 17:07 PM EDT
The company, which went public in 2017, is developing drugs to help patients with autoimmune and inflammatory diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|